Macular degeneration is a progressive eye condition affecting the central part of the retina, known as the macula. This area is crucial for sharp, central vision needed for activities like reading and driving. There are two types: dry macular degeneration, characterized by the gradual thinning of the macular tissue, and wet macular degeneration, marked by abnormal blood vessel growth under the retina.
Risk factors include aging, genetics, smoking, and prolonged sun exposure. Symptoms may include blurry or distorted central vision, straight lines appearing wavy, and difficulty recognizing faces. While there is no cure, early detection through regular eye exams is crucial for managing the condition and preventing severe vision loss. Treatment options vary depending on the type and severity, ranging from dietary supplements and lifestyle changes to injections or laser therapy for wet macular degeneration. Ongoing research aims to develop more effective therapies to preserve vision and improve quality of life for those affected.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom